已收盘 08-29 16:00:00 美东时间
-0.530
-1.92%
Drug developers with products targeting a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Wednesday after the U.S. FDA said it has accepted an easy-to-m...
08-28 01:44
Viking Therapeutics (NASDAQ:VKTX), often touted as an attractive obesity play, shed more than a third of its value this week after mid-stage trial data for its oral obesity candidate VK2735 disappoint...
08-24 02:00
Viking Therapeutics ( ($VKTX) ) has fallen by -38.23%. Read on to learn why. Vi...
08-23 22:02
鲍威尔“送利好”!OpenDoor周内暴涨58%,明星投资人称降息对公司非常重要;名创优品半年报亮眼,周内飙涨35%;蔚来全新ES8上市带动股价大涨31%>>
08-23 10:22
高盛本周发布关于Viking Therapeutics(VKTX.US)近期试验结果的评论报告,该试验顶线结果积极,该行给予33美元目标价。
08-21 16:15
Investors betting against Viking Therapeutics (NASDAQ:VKTX) netted a one-day paper profit of $521M as the shares of the San Diego, California-based biotech sold off on Tuesday in reaction to mid-stage...
08-20 18:54
Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it's inferior.
08-20 15:53
影响股市利好与利空消息 宏观新闻 1、财政部数据显示,1—7月,全国一般公共预算收入135839亿元,同比增长0.1%。其中,全国税收收入11093...
08-20 08:38
周二,Viking Therapeutics Inc.创下史上最大股价跌幅,让做空该公司的交易员获得巨额收益,一举扭转了今年以来的亏损局面。
08-20 07:18
TradingKey - 週二,Viking Therapeutics(VKTX.US)的股價遭遇大幅暴跌,跌幅超過42%,這場暴跌源自於該公司公佈的中期試驗數據,在副作用問題上表現不佳,令投資人大失所望。這家專注於肥胖症藥物開發的生物科技公司,股價從週一收盤時的42.09美元驟降至週二收盤的24.36美元,盤中最低觸及23.21美元,Viking的市值也從週一的40多億美元縮水至27.39億美元。
08-20 04:03